Spago Nanomedical conducts research and development in cancer diagnostics. The company conducts various development projects based on its proprietary nanomaterials whose potential is found in making tumours visible, and enabling internal radiation therapy of cancer. The company was founded in 2007 and is based in Lund.

Quotes for Spago Nanomedical AB

Right Now

+/-
-0.3
%
-2,70%
Latest
10.8
High
11.2
Low
10.8
Volume
11 929
Turnover (SEK)
129 874
Value (MSEK)
227,1

Board

CEO

  • Mats Hansen

Chairman Of The Board

  • Eugen Steiner

Board

  • Kari Grønås
  • Nicklas Westerholm
  • Peter Leander
  • Peter Wulff
  • Sten Nilsson

Videos

Largest Owners

Name Capital % Votes % Date
Peter Lindell 18,08 18,08 2019-12-31
HealthInvest Partners 7,80 7,80 2020-01-31
Avanza Pension 7,58 7,58 2019-12-31
Eva Redhe 7,14 7,14 2019-09-30
Mikael Lönn 6,28 6,28 2019-12-31
Andreas Bunge med närstående 4,56 4,56 2019-09-30
Thord Wilkne 4,39 4,39 2019-12-31
Tiel Ridderstad 4,36 4,36 2019-09-30
Ranny Davidoff 4,33 4,33 2019-09-30
Claes Dahlbäck 2,42 2,42 2019-12-31
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream